Glucocorticoid receptor polymorphisms in major depression

65Citations
Citations of this article
88Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Major depressive disorder (MDD) often appears after exposure to acute or chronic stress, and dysfunction of stress response systems, such as the hypothalamic-pituitary-adrenal (HPA) axis, is thought to be a key element of MDD neurobiology. The glucocorticoid receptor (GR) is the most important regulator of the HPA axis negative feedback system, and GR sensitivity has been shown to be reduced in MDD in both in vitro and in vivo studies. Transgenic animals with partial impairment of GR function show behavioral changes consistent with MDD. This makes the GR gene a prime candidate for research into the genetic background of MDD. Several single nucleotide polymorphisms (SNPs) have been detected that have specific effects on GR function, metabolic parameters, and HPA axis function in response to stress. Genetic association studies have yielded preliminary evidence for a role of these genetic variations in the genetic vulnerability for MDD. Taken together, the evidence for a role of GR and the GR gene in the neurobiology of MDD is building rapidly. © 2009 New York Academy of Sciences.

Cite

CITATION STYLE

APA

Claes, S. (2009). Glucocorticoid receptor polymorphisms in major depression. In Annals of the New York Academy of Sciences (Vol. 1179, pp. 216–228). Blackwell Publishing Inc. https://doi.org/10.1111/j.1749-6632.2009.05012.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free